Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Eckerdt

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|September 21, 2017
Polo-like kinase 1 inhibitors SBE13 and BI 2536 induce different responses in primary cellsFrank Eckerdt
Cancer Research|July 20, 2006
Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysisFrank Eckerdt, Klaus Strebhardt
Trends in Biochemical Sciences|September 27, 2008
Kicking off the polo gameFrank Eckerdt, James L Maller
Cancers|July 14, 2023
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy ResistanceFrank Eckerdt, Leonidas C Platanias
Oncogene|January 11, 2005
Polo-like kinases and oncogenesisFrank Eckerdt, Juping Yuan, Klaus Strebhardt
Cancer Cell & Microenvironment|June 23, 2015
New insights into malignant cell survival mechanisms in medulloblastomaFrank Eckerdt, Stewart Goldman, Leonidas C Platanias
Plos One|January 30, 2014
LIN-9 phosphorylation on threonine-96 is required for transcriptional activation of LIN-9 target genes and promotes cell cycle progressionFrank Eckerdt, Mathew Perez-Neut, Oscar R Colamonici
Cancers|May 25, 2024
Schlafens: Emerging Therapeutic TargetsRicardo E Perez, Frank Eckerdt, Leonidas C Platanias
Cancer Research|August 3, 2002
Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferationJuping Yuan, Andrea Krämer, Frank Eckerdt, et al.
BMC Cancer|October 13, 2006
Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neckChristine Solbach, Marc Roller, Frank Eckerdt, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|September 21, 2017
Polo-like kinase 1 inhibitors SBE13 and BI 2536 induce different responses in primary cellsFrank Eckerdt
Cancer Research|July 20, 2006
Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysisFrank Eckerdt, Klaus Strebhardt
Trends in Biochemical Sciences|September 27, 2008
Kicking off the polo gameFrank Eckerdt, James L Maller
Cancers|July 14, 2023
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy ResistanceFrank Eckerdt, Leonidas C Platanias
Oncogene|January 11, 2005
Polo-like kinases and oncogenesisFrank Eckerdt, Juping Yuan, Klaus Strebhardt
Cancer Cell & Microenvironment|June 23, 2015
New insights into malignant cell survival mechanisms in medulloblastomaFrank Eckerdt, Stewart Goldman, Leonidas C Platanias
Plos One|January 30, 2014
LIN-9 phosphorylation on threonine-96 is required for transcriptional activation of LIN-9 target genes and promotes cell cycle progressionFrank Eckerdt, Mathew Perez-Neut, Oscar R Colamonici
Cancers|May 25, 2024
Schlafens: Emerging Therapeutic TargetsRicardo E Perez, Frank Eckerdt, Leonidas C Platanias
Cancer Research|August 3, 2002
Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferationJuping Yuan, Andrea Krämer, Frank Eckerdt, et al.
BMC Cancer|October 13, 2006
Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neckChristine Solbach, Marc Roller, Frank Eckerdt, et al.
Pageof 4